INFevo

China · Biotech · AI

Develops virtual-cell AI models and automated experimental workflows for biological research.

Product

INFevo develops AI models that predict how cells respond to drugs, genetic changes and other interventions. Its OCOO models work alongside automated cell experiments, allowing laboratory results to feed back into subsequent predictions.

Incubated by XtalPi, the company also develops Karl Workbench, a biological-research workspace for analysing data and testing scientific hypotheses. The platform is in beta and connects research questions, analyses and evidence across successive experiments.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-A>CN¥100MDT Capital Partners — ParticipantHongShan — ParticipantHuagai Capital — ParticipantHuakong Fund — ParticipantLINK-X CAPITAL — ParticipantProsperity7 — ParticipantShunwei Capital — Participant
Sources36kr.com ↗xtalpi.com ↗